Status:
COMPLETED
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
Lead Sponsor:
Novartis
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
SAFETY EXTENSION STUDY TO THE CORE STUDY CVAH631C2301
Eligibility Criteria
Inclusion
- SUCCESSFUL COMPLETION OF STUDY CVAH631C2301
- \-
Exclusion
- NONE
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
836 Patients enrolled
Trial Details
Trial ID
NCT00241007
Start Date
December 1 2003
End Date
March 1 2005
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis Pharmaceuticals
East Hanover, New Jersey, United States, 07936